|My name is Angela Gonzalez and I am a 66-year-old resident of Bridgeport, Connecticut. I have COPD, a chronic issue for me that affects my daily life. It’s hard to breathe sometimes, which is why my doctor prescribed me inhalers. I have been on Advair Diskus and Breo Ellipta inhalers, both of which are produced by the drug corporation GlaxoSmithKline.
My doctor prescribed the Advair Diskus to me first, and I used the inhaler for years before ultimately switching to Breo. My insurance covers 80% of the cost, but I am still left to pay $45. However, sometimes the price is up to $450 for an inhaler when I enter the Medicare donut hole.
I now take Breo Ellipta, which costs the same price as the Advair. Because of the high price of my Breo, I skip doses. I have a hard time paying for my inhaler, and because I have to skip doses, it is harder for me to breathe. Sometimes, my whole body starts hurting.
If I weren’t able to cover my co-pay, I wouldn’t be able to access my inhalers at all. I don’t even want to think about that –– I know it would be terrible for my health. I rely on these GlaxoSmithKline inhalers to breathe, but sometimes I feel that the price of these drugs put that out of reach.